Tatjana Stankovic

1 - 78 out of 78Page size: 100

Publications

  1. 2020
  2. Published

    Aniline-containing derivatives of parthenolide: Synthesis and anti-chronic lymphocytic leukaemia activity

    Tatjana Stankovic, Angelo Agathanggelou & John Fossey, 27 Nov 2020, In: Tetrahedron. 76, 48, 131631.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Genetics in the era of targeted CLL therapy

    Tatjana Stankovic & Marwan Cheng Kuang Kwok, 25 Jun 2020, In: Blood. 135, 26, p. 2333-2334 2 p.

    Research output: Contribution to journal › Comment/debate › peer-review

  4. Published

    Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL: natural history and mechanism of spontaneous CLL regression

    Marwan Cheng Kuang Kwok, Ceri Oldreive, Anshita Goel, Grigorios Papatzikas, Samantha Drennan, Angelo Agathanggelou, Archana Sharma-Oates, Robert Hollows, Nick Davies, Helen Parry, Andrew Beggs & 10 others, , Malcolm Taylor, Jean-Baptiste Cazier, Paul Moss & Tatjana Stankovic, 6 Feb 2020, In: Blood. 135, 6, p. 411-428 18 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2019
  6. Published

    Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia

    Helen Parry, Jianmin Zuo, Heather Long, Marwan Cheng Kuang Kwok, Tatjana Stankovic & Paul Moss, 12 Dec 2019, In: Frontiers in immunology. 10, 2832.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia

    Ruth Roberts & 4 others, Tatjana Stankovic, John Fossey & Angelo Agathanggelou, 1 Aug 2019, In: Medchemcomm. 10, 8, p. 1379-1390 12 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    PALB2 variant status in hematological malignancies - a potential therapeutic target?

    Ceri Oldreive, Philip Byrd, Grant Stewart, Malcolm Taylor, Manoj Raghavan, Nick Davies, Marwan Cheng Kuang Kwok, Dickens Pratt, Paul Moss, Tatjana Stankovic & Malcolm Taylor, 7 Jan 2019, In: Leukemia and Lymphoma. 60, 7, p. 1823-1826 4 p.

    Research output: Contribution to journal › Letter › peer-review

  9. Published

    Targeting the Ataxia Telangiectasia and Rad3 Signaling Pathway to Overcome Chemoresistance in Cancer

    Marwan Cheng Kuang Kwok & Tatjana Stankovic, 2019, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. Johnson, D. E. (ed.). Elsevier, Vol. 3. p. 203-230

    Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review

  10. 2018
  11. Published

    Targeting Replication Stress in Sporadic Tumours

    Marwan Cheng Kuang Kwok & Tatjana Stankovic, 4 Sep 2018, DNA Repair and Replication: Mechanisms and Cinical Significance. Grand, R. J. A. & Reynolds, J. J. (eds.). 1st ed. CRC Press, p. 329-340 22 p.

    Research output: Chapter in Book/Report/Conference proceeding › Chapter (peer-reviewed) › peer-review

  12. Published

    A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma

    Christina Yap, Ceri Oldreive, Daniel Slade, Paul Moss & Tatjana Stankovic, Aug 2018, In: British Journal of Haematology. 182, 3, p. 429-433

    Research output: Contribution to journal › Letter › peer-review

  13. Published

    CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Angelo Agathanggelou, Paul Moss & 4 others, , Tatjana Stankovic, 12 Jul 2018, In: Nature. 559, 7713, p. 285-289 5 p.

    Research output: Contribution to journal › Article › peer-review

  14. Published

    Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukaemia (ALL) cells to cytotoxic agents and involves down-regulation of STAT6 and PDAP1

    Wenbin Wei, Tatjana Stankovic & Pamela Kearns, 1 Jul 2018, In: Experimental Hematology. 63, p. 52-63.e5

    Research output: Contribution to journal › Article › peer-review

  15. 2017
  16. Published

    USP7 inhibition alters homologous recombination repair and targets CLL cells independent of ATM/p53 functional status

    Angelo Agathanggelou, Nick Davies, Marwan Cheng Kuang Kwok, Anastasia Zlatanou, Ceri Oldreive, Tracey Perry, Pamela Kearns, Anna Skowronska, Helen Parry, Dickens Pratt, Paul Moss & 3 others, Malcolm Taylor, Grant Stewart & Tatjana Stankovic, 13 Jul 2017, In: Blood. 130, 2, p. 156–166

    Research output: Contribution to journal › Article › peer-review

  17. Published

    Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts

    Nick Davies, Marwan Cheng Kuang Kwok, Ceri Oldreive, Helen Parry, Angelo Agathanggelou, Dickens Pratt, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 26 Apr 2017, In: OncoTarget. 8, 27, p. 44749-44760

    Research output: Contribution to journal › Article › peer-review

  18. 2016
  19. Published

    NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma

    Helen Parry, Ceri Oldreive, Tatjana Stankovic, Dickens Pratt, Jianmin Zuo & Paul Moss, 17 Sep 2016, In: OncoTarget. 7, p. 68513-68526

    Research output: Contribution to journal › Article › peer-review

  20. Published

    A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development

    Philip Byrd, Grant Stewart, Malcolm Taylor, James Last, Tatjana Stankovic & Malcolm Taylor, 18 Mar 2016, In: PLoS Genetics. 12, 3, e1005945.

    Research output: Contribution to journal › Article › peer-review

  21. Published

    ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 or ATM defective chronic lymphocytic leukemia cells

    Marwan Cheng Kuang Kwok, Nick Davies, Angelo Agathanggelou, Ceri Oldreive, Eva Petermann, Grant Stewart, Dickens Pratt, Helen Parry, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 4 Feb 2016, In: Blood. 127, 5, p. 582-595

    Research output: Contribution to journal › Article › peer-review

  22. E-pub ahead of print

    Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia

    Tatjana Stankovic, Ceri Oldreive & 6 others, , 2 Feb 2016, In: Blood.

    Research output: Contribution to journal › Article › peer-review

  23. 2015
  24. Published

    Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

    Ceri Oldreive, Nick Davies, Anna Skowronska, Marwan Cheng Kuang Kwok, Paul Moss, Michael Griffiths, Malcolm Taylor & Tatjana Stankovic, 3 Dec 2015, Blood. American Society of Hematology, Vol. 126. p. 167 (Blood).

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  25. Published

    T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice

    Ceri Oldreive, Nick Davies, Helen Parry, Angelo Agathanggelou, Laura Cronin, Katerina Vrzalikova, Elena Odintsova, Dickens Pratt, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 28 Oct 2015, In: Disease Models and Mechanisms. 8, p. 1401-1412 12 p.

    Research output: Contribution to journal › Article › peer-review

  26. Published

    Targeting the ataxia telangiectasia mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants

    Angelo Agathanggelou, Victoria Weston, Tracey Perry, Nick Davies, John Fossey, Ceri Oldreive, Wenbin Wei, Dickens Pratt, Paul Moss, Grant Stewart, Malcolm Taylor & 1 others, Tatjana Stankovic, 31 Aug 2015, In: Haematologica. 100, 8, p. 1076-1085 10 p.

    Research output: Contribution to journal › Article › peer-review

  27. Published

    Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

    Alan Parker, Tony Gardiner, Zoe Davies, Tatjana Stankovic & 1 others, , 10 Aug 2015, In: Leukemia.

    Research output: Contribution to journal › Article › peer-review

  28. Published

    Bod1l is required to suppress deleterious resection of stressed replication forks

    Martin Higgs, John Reynolds, Anastasia Zlatanou, Nick Davies, Tatjana Stankovic & Grant Stewart, 6 Aug 2015, In: Molecular Cell. 59, 3, p. 462-477

    Research output: Contribution to journal › Article › peer-review

  29. Published

    TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells

    Tatjana Stankovic, 1 Aug 2015, In: Journal of Immunology. 195, 3, p. 901-23 23 p.

    Research output: Contribution to journal › Article › peer-review

  30. Published

    The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53

    Sarah Berhane, Ceri Oldreive, Anastasia Zlatanou, Victoria Weston, Tatjana Stankovic, Pamela Kearns, Roger Grand, Jun 2015, In: Oncogene. 34, 25, p. 3336-3348 13 p.

    Research output: Contribution to journal › Article › peer-review

  31. Published

    The impact of SF3B1 mutations in CLL on the DNA-damage response

    Ceri Oldreive, Tatjana Stankovic, May 2015, In: Leukemia. 29, 5, p. 1133-42 10 p.

    Research output: Contribution to journal › Article › peer-review

  32. Published

    Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway

    Marwan Cheng Kuang Kwok, Nick Davies, Angelo Agathanggelou, Eva Petermann & Tatjana Stankovic, 26 Feb 2015, In: The Lancet. 385 Suppl 1, p. S58

    Research output: Contribution to journal › Abstract › peer-review

  33. Published

    Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

    Tatjana Stankovic, 2015, In: Cell death & disease. 6, p. e1852

    Research output: Contribution to journal › Article › peer-review

  34. Published

    USP7 is essential for maintaining Rad18 stability and DNA damage tolerance

    Anastasia Zlatanou, Grant Stewart, Angelo Agathanggelou, Tatjana Stankovic, 2015, In: Oncogene.

    Research output: Contribution to journal › Article › peer-review

  35. 2014
  36. Published

    ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy

    Marwan Cheng Kuang Kwok, Nick Davies, Angelo Agathanggelou, Eva Petermann & Tatjana Stankovic, 6 Dec 2014, Blood. Vol. 124. p. 3340 (Blood).

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  37. Published

    CLL Progression Is Associated with Increased Clonal Diversity and Replication Stress

    Angelo Agathanggelou, Anna Skowronska, Nick Davies, Marwan Cheng Kuang Kwok, Malcolm Taylor & Tatjana Stankovic, 6 Dec 2014, Blood. Vol. 124. p. 1977 (Blood).

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  38. Published

    Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach

    Tatjana Stankovic, Nov 2014, In: British Journal of Haematology. 167, 4, p. 565-9 5 p.

    Research output: Contribution to journal › Article › peer-review

  39. Published

    The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia

    Tatjana Stankovic, Jun 2014, In: Leukemia and Lymphoma. 55, 6, p. 1227-39 13 p.

    Research output: Contribution to journal › Article › peer-review

  40. Published

    ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial

    Tatjana Stankovic, Apr 2014, In: Haematologica. 99, 4, p. 736-42 7 p.

    Research output: Contribution to journal › Article › peer-review

  41. 2013
  42. Published

    Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

    Tatjana Stankovic, Nick Davies, Marwan Cheng Kuang Kwok, Angelo Agathanggelou, 15 Nov 2013, Blood. Vol. 122. p. 120 (Blood).

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

  43. Published

    Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia

    Tatjana Stankovic, Aug 2013, In: Leukemia and Lymphoma. 54, 8, p. 1849-53 5 p.

    Research output: Contribution to journal › Article › peer-review

  44. Published

    BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia

    Angelo Agathanggelou, Victoria Weston, Eva Petermann, Anastasia Zlatanou, Ceri Oldreive, Wenbin Wei, Grant Stewart, Emma Smith, Pamela Kearns & Tatjana Stankovic, Jul 2013, In: Blood Cancer Journal. 3, 7, e126.

    Research output: Contribution to journal › Article › peer-review

  45. Published

    PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains

    Tatjana Stankovic, 1 Jun 2013, In: Cancer Research. 73, 11, p. 3336-46 11 p.

    Research output: Contribution to journal › Article › peer-review

  46. 2012
  47. Published

    Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage

    Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In: Leukemia. 26, 4, p. 826-830 5 p.

    Research output: Contribution to journal › Article

  48. Published

    A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia

    Tatjana Stankovic, 1 Mar 2012, In: Leukemia Research. 36, 3, p. 307-310 4 p.

    Research output: Contribution to journal › Article

  49. Published

    KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia

    Tatjana Stankovic, Eamonn Maher & Farida Latif, 1 Mar 2012, In: Epigenetics : official journal of the DNA Methylation Society. 7, 3, p. 211-215 5 p.

    Research output: Contribution to journal › Article

  50. Published

    Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

    Anna Skowronska, Ceri Oldreive, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2012, In: Journal of Clinical Oncology . 30, 36, p. 4524-4532 9 p.

    Research output: Contribution to journal › Article › peer-review

  51. 2011
  52. Published

    ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele

    Anna Skowronska, Judy Powell, Victoria Weston, Dickens Pratt, Paul Moss, Malcolm Taylor & Tatjana Stankovic, 20 Sep 2011, In: Haematologica. 97, 1, p. 142-146 5 p.

    Research output: Contribution to journal › Article

  53. 2010
  54. Published

    The PARP inhibitor olaparib induces significant killing of ATM deficient lymphoid tumour cells in vitro and in vivo.

    Victoria Weston, Ceri Oldreive, Anna Skowronska, Dickens Pratt, Judy Powell, Pamela Kearns, Paul Moss, Malcolm Taylor & Tatjana Stankovic, 25 Nov 2010, In: Blood. 116, 22, p. 4578-87 10 p.

    Research output: Contribution to journal › Article › peer-review

  55. Published

    Induction of a CD8(+) T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

    Oliver Goodyear, Angelo Agathanggelou, Igor Novitzky Basso, Gordon Ryan, Tatjana Stankovic, Paul Moss & Charles Craddock, 1 Sep 2010, In: Blood. 116, 11, p. 1908-1918 11 p.

    Research output: Contribution to journal › Article

  56. 2009
  57. Published

    Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia

    Tatjana Stankovic, Ashraf Dallol, Victoria Weston, Eamonn Maher & Farida Latif, 1 May 2009, In: Epigenetics : official journal of the DNA Methylation Society. 4, 4, p. 265-269 5 p.

    Research output: Contribution to journal › Article

  58. Published

    The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage.

    Grant Stewart, Kelly Townsend, Ceri Oldreive, Philip Byrd, Tatjana Stankovic, Malcolm Taylor, 6 Feb 2009, In: Cell. 136, 3, p. 420-34 15 p.

    Research output: Contribution to journal › Article

  59. Published

    The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma.

    Shikha Bose, Matthew Fung, Christopher Dawson, Wenbin Wei, John Arrand, Lawrence Young, Tatjana Stankovic & Paul Murray, 1 Feb 2009, In: Journal of Pathology. 217, 3, p. 345-52 8 p.

    Research output: Contribution to journal › Article

  60. Published

    Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response.

    Victoria Weston, Esther Maina, Carmel McConville, Angelo Agathanggelou, Anna Skowronska, Judy Powell, Pamela Kearns, Francesco Falciani, Malcolm Taylor & Tatjana Stankovic, 1 Jan 2009, In: Blood. 113, 1, p. 117-26 10 p.

    Research output: Contribution to journal › Article › peer-review

  61. 2008
  62. Published

    Functional modules integrating essential cellular functions are predictive of the response of leukaemia cells to DNA damage.

    Philipp Antczak, Nil Turan Jurdzinski, Tatjana Stankovic & Francesco Falciani, 15 Nov 2008, In: Bioinformatics. 24, 22, p. 2602-7 6 p.

    Research output: Contribution to journal › Article

  63. Published

    Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

    Dickens Pratt, Tatjana Stankovic, 1 Nov 2008, In: Blood. 112, 9, p. 3807-3817 11 p.

    Research output: Contribution to journal › Article

  64. Published

    Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients

    Giancarlo Barone, Anne Reiman, Philip Byrd, Tatjana Stankovic, Dickens Pratt & Malcolm Taylor, 1 Sep 2008, In: British Journal of Haematology. 142, 6, p. 925-933 9 p.

    Research output: Contribution to journal › Article

  65. Published

    A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL

    Anna Skowronska, Tatjana Stankovic, 1 Jul 2008, In: Leukemia. 22, 7, p. 1456-1459 4 p.

    Research output: Contribution to journal › Article

  66. Published

    A Regulatory Role for NBS1 in Strand-Specific Mutagenesis during Somatic Hypermutation

    Tatjana Stankovic, Malcolm Taylor, 1 Jun 2008, In: PLoS ONE. 3, 6, 11 p., e2482.

    Research output: Contribution to journal › Article › peer-review

  67. Published

    ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia

    Andrew Bell, Dickens Pratt, Tatjana Stankovic & Paul Moss, 1 Apr 2008, In: International Journal of Laboratory Hematology. 30, 2, p. 149-157 9 p.

    Research output: Contribution to journal › Article

  68. Published

    Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemia

    Tatjana Stankovic, 1 Mar 2008, In: Srpski arhiv za celokupno lekarstvo. 136, 3-4, p. 187-192 6 p.

    Research output: Contribution to journal › Review article

  69. 2007
  70. Published

    Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion

    Judy Powell, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Dec 2007, In: Journal of Clinical Oncology. 25, 34, p. 5448-57 10 p.

    Research output: Contribution to journal › Article

  71. Published

    Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation

    Karl Baumforth, Philip Byrd, Malcolm Taylor, Paul Murray & Tatjana Stankovic, Nov 2007, In: Journal of Pathology. 213, 3, p. 329-36 8 p.

    Research output: Contribution to journal › Article › peer-review

  72. Published

    RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling

    Grant Stewart, Tatjana Stankovic, Philip Byrd, Aarnoud Huissoon, Mark Drayson & Malcolm Taylor, 23 Oct 2007, In: National Academy of Sciences. Proceedings. 104, 43, p. 16910-5 6 p.

    Research output: Contribution to journal › Article

  73. 2005
  74. Published

    Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells

    Karl Baumforth, Joanne Gough, Trevor Pettitt, Wenbin Wei, Susan Morgan, Tatjana Stankovic, Dickens Pratt, Mike Wakelam, Lawrence Young & Paul Murray, 15 Sep 2005, In: Blood. 106, p. 2138-2146 9 p.

    Research output: Contribution to journal › Article

  75. Published

    Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumour suppressor gene mutations in clonally related composite Hodgkin and non-Hodgkin lymphomas

    Tatjana Stankovic, Belinda Austen, 23 Jun 2005, In: Leukemia. 19, p. 1452-1458 7 p.

    Research output: Contribution to journal › Article

  76. Published

    A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival

    Azra Alvi, Belinda Austen, Victoria Weston, Judy Powell, Wenbin Wei, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 1 Jun 2005, In: Blood. 105, p. 4484-4491 8 p.

    Research output: Contribution to journal › Article

  77. Published

    Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL

    Belinda Austen, Judy Powell, Azra Alvi, Malcolm Taylor, Paul Moss & Tatjana Stankovic, 2005, In: Blood. 106, 9, p. 3175-82 8 p.

    Research output: Contribution to journal › Article › peer-review

  78. 2004
  79. Published

    Apoptotic resistance to ionizing radiation in paediatric B-precursor acute lymphoblastic leukaemia frequently involves increased NF-κB survival pathway signalling

    Victoria Weston, Belinda Austen, Wenbin Wei, Azra Alvi, Paul Moss, Malcolm Taylor & Tatjana Stankovic, 1 Jan 2004, In: Blood. 104, p. 1465-1473 9 p.

    Research output: Contribution to journal › Article

  80. Published

    Clinical, cellular and mutational variations in ataxia telangiectasia

    Malcolm Taylor, Grant Stewart, Tatjana Stankovic, Philip Byrd, 1 Jan 2004, Genetic Predisposition to cancer. Eeles, R. (ed.). 2nd ed. Arnold

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

  81. Published

    Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses

    Tatjana Stankovic, Grant Stewart, Colin Bignell, Azra Alvi, Belinda Austen, Victoria Weston, Philip Byrd, Paul Moss & Malcolm Taylor, 1 Jan 2004, In: Blood. 103, p. 291-300 10 p.

    Research output: Contribution to journal › Article

  82. Published

    Rac1 and Rac2 GTPases in haematopoiesis

    Victoria Weston & Tatjana Stankovic, 1 Jan 2004, In: BioEssays. 26, p. 221-224 4 p.

    Research output: Contribution to journal › Review article

  83. 2003
  84. Published

    Variations in ATM protein expression during normal lymphoid differentiation and among B-cell derived neoplasias

    Joanne Gough, Philip Byrd, Grant Stewart, Paul Moss, Malcolm Taylor, Tatjana Stankovic & Paul Murray, 1 Jan 2003, In: The American Journal of Pathology. 163, p. 423-432 10 p.

    Research output: Contribution to journal › Article

  85. 2002
  86. Published

    An unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL

    Victoria Weston, Tatjana Stankovic, Mark Drayson, 6 Nov 2002, In: Leukemia. 16, 11, p. 2337-2339 3 p.

    Research output: Contribution to journal › Article

  87. Published

    ATM mutations in sporadic lymphoid tumours

    Tatjana Stankovic, Grant Stewart, Philip Byrd, Paul Moss & Malcolm Taylor, 1 Jan 2002, In: Leukemia and Lymphoma. 43, p. 1563-1571 9 p.

    Research output: Contribution to journal › Article

  88. Published

    Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukaemia occurs in pre-germinal center cells and results in defective damage response and unrepaired chromosome damage

    Tatjana Stankovic, Grant Stewart, James Last, Philip Byrd, Russell Keenan, Paul Moss & Malcolm Taylor, 1 Jan 2002, In: Blood. 99, 1, p. 300-309 10 p.

    Research output: Contribution to journal › Article

  89. 2001
  90. Published

    Molecular analysis of single colonies reveals a diverse origin of initial clonal proliferation in B-precursor acute lymphoblastic leukaemia that can precede the t(12;21) translocation

    Victoria Weston, Carmel McConville, John Gordon, Paul Moss, Malcolm Taylor & Tatjana Stankovic, 1 Dec 2001, In: Cancer Research. 61, p. 8547-8553 7 p.

    Research output: Contribution to journal › Article

  91. Published

    Residual ATM protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T->G mutations, showing a less severe phenotype

    Grant Stewart, James Last, Tatjana Stankovic, Philip Byrd & Malcolm Taylor, 3 Aug 2001, In: Journal of Biological Chemistry. 276, 32, p. 30133-30141 9 p.

    Research output: Contribution to journal › Article

  92. Published

    p53 dysfunction in B cell chronic lymphocytic leukaemia: Inactivation of ATM as an alternative to a TP53 mutation

    Grant Stewart, Malcolm Taylor & Tatjana Stankovic, 1 Aug 2001, In: Blood. 98, 3, p. 814-822 9 p.

    Research output: Contribution to journal › Article

  93. Published

    hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay.

    Harjit Kullar, Tatjana Stankovic, Grant Stewart, James Last, Susan Armstrong, Malcolm Taylor & Philip Byrd, 15 May 2001, In: Human Molecular Genetics. 10, 11, p. 1155-62 8 p.

    Research output: Contribution to journal › Article

  94. Published

    Recurrent ATM mutations in T-PLL on diverse haplotypes: No support for their germline origin

    Tatjana Stankovic, Malcolm Taylor, 1 Mar 2001, In: Blood. 97, 5, p. 1517-1518 2 p.

    Research output: Contribution to journal › Article

  95. 2000
  96. Published

    Clonal diversity of lg and T-cell receptor gene rearrangements in childhood B-precursor scute lymphoblastic leukaemia

    Tatjana Stankovic, Victoria Weston, Carmel McConville, Judy Powell & Malcolm Taylor, 1 Jan 2000, In: Leukemia and Lymphoma. 36, p. 213-224 12 p.

    Research output: Contribution to journal › Review article

  97. Published

    In vitro culture system identifies TEL/AML1 negative pre-leukaemic subclones in a t(12;21) positive B-precursor ALL case

    Carmel McConville, John Gordon, Paul Moss & Tatjana Stankovic, 1 Jan 2000, In: Blood. 96, p. 465 1 p.

    Research output: Contribution to journal › Article

  98. 1999
  99. Published

    The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder

    Grant Stewart, Tatjana Stankovic, Philip Byrd, 10 Dec 1999, In: Cell. 99, 6, p. 577-87 11 p.

    Research output: Contribution to journal › Article › peer-review